Revium Rx Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2009	FY 2008
Period Ending	Sep '25 Sep 16, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '09 Dec 31, 2009	Dec '08 Dec 31, 2008
Market Capitalization	32	23	52	43	1	-
Market Cap Growth	1038.50%	-55.43%	20.71%	5974.83%	-	-
Enterprise Value	26	24	52	44	1	-
Last Close Price	0.52	0.40	1.50	1.49	15.00	25.00
PS Ratio	-	-	-	-	1.08	-
PB Ratio	1.63	1.18	37.45	110.75	0.82	-
P/TBV Ratio	8.21	5.56	37.45	110.75	-	-
P/FCF Ratio	-	-	-	-	0.22	-
P/OCF Ratio	-	-	-	-	0.22	-
EV/Sales Ratio	-	-	-	-	1.37	-
EV/FCF Ratio	-18.21	-	-	-	0.28	-
Debt / Equity Ratio	0	0	-	0.00	0.23	0.05
Debt / FCF Ratio	-	-	-	-	0.06	-
Asset Turnover	-	-	-	-	0.16	-
Quick Ratio	8.90	9.24	8.06	6.24	0.07	1.16
Current Ratio	9.39	9.58	9.32	6.53	0.41	1.27
Return on Equity (ROE)	-	-33.23%	-110.77%	-	-2.97%	-
Return on Assets (ROA)	-	-20.42%	-62.04%	-	-1.61%	-
Return on Capital (ROIC)	-	-21.14%	-70.25%	-	-1.73%	-
Return on Capital Employed (ROCE)	-	-	-	-	-	1.50%
Earnings Yield	-6.55%	-15.09%	-1.89%	-2.81%	-14.59%	-
FCF Yield	-4.51%	-5.22%	-1.95%	-1.91%	454.66%	-
Buyback Yield / Dilution	-90590.53%	-106.85%	-4.44%	-48170.60%	15.69%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.